UNC119B

Across TCGA pan-cancer cohorts, UNC119B mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of UNC119B’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where UNC119B mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types UNC119B is over-expressed in tumor, although a few such as HNSC and LSCC show the opposite, repressed pattern.

CCRCC, HNSC, and LSCC are the cancer types where UNC119B tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UNC119B mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	+0.451	<.001	12	view →
HNSC	All	III,IV	−0.288	<.001	11	view →
LSCC	Female	All	−0.182	<.001	7	view →
LUAD	All	All	−0.087	.002	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

UNC119B–CCRCC

Open the CCRCC breakdown →